Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is seeking a scientifically talented and motivated individual to join our Integrated Discovery Research team as Associate Director, Analytical Chemistry. This role will drive analytical chemistry efforts within the Medicinal Chemistry function and collaborate cross-functionally to support our drug discovery programs from early hit identification through lead optimization and candidate selection. Reporting to the Director of Medicinal Chemistry, this position offers a unique opportunity to shape analytical science at the frontiers of small molecule beyond Rule-of-Five (bRo5) drug discovery.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree